Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COMPARE STEMI ONE- Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients Treated With OCT-guided vs aNgio-guided completE Revascularization

NCT05491200 is registered in ClinicalTrials.gov with Research Maatschap Cardiologen Rotterdam Zuid as lead sponsor.

NCT NCT05491200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05491200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COMPARE STEMI ONE- Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients Treated With OCT-guided vs aNgio-guided completE Revascularization
Lead sponsor
Research Maatschap Cardiologen Rotterdam Zuid
Phase
Phase 4
Overall status
Recruiting
Start date
July 22, 2022
Completion date
August 1, 2029
Enrollment
1,656 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

dual antiplatelet therapy, st elevated myocardial infarction